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1. Introduction 
Sildenafil citrate is widely used as an effective and safe oral treatment for erectile 
dysfunction of various etiologies (Goldstein et al., 1998; Cheitlin et al., 1999; Benchekroun et 
al., 2003). It is a potent and selective inhibitor of phosphodiesterase type 5 enzymes that acts 
to break down cyclic guanosine monophosphate (cGMP) (Boolell et al., 1996). The 
medication amplifies the effect of sexual stimulation by retarding the degradation of this 
enzyme. Sildenafil has been found effective in several subpopulations of men with erectile 
dysfunction, including sufferers from diabetes (Basu and Ryder, 2004), hypertension 
(Feldman et al., 1999), spinal cord injuries (Hultling et al., 2000; Deforge et al., 2006), multiple 
sclerosis (Fowler et al., 2005), depression (Seidman et al., 2001; Rosen et al., 2004; Tignol et 
al., 2004; Fava et al., 2006), PTSD (Orr et al., 2006), and schizophrenia (Aviv et al., 2004; 
Gopalakrishnan et al., 2006), men after resection of the prostate or radical prostatectomy 
(Nandipati et al., 2006), after renal transplant (Sharma et al., 2006), men on dialysis (Dachille 
et al., 2006), and men aged 65 years and older (Wagner et al., 2001; Carson, 2004).  
 Psychogenic erectile dysfunction (ED) patients are excellent candidates for sildenafil citrate 
therapy due to the intact neurovascular pathway. Nevertheless, the drug has been reported 
to be effective only in about 78% of patients with psychogenic ED (McMahon et al., 2000). It 
is likely that performance anxiety and sympathetic overtone are the cause of this 
unresponsiveness to sildenafil citrate during awakening, though data supporting this 
assumption are lacking (Rosen, 2001). The drug has been found to be effective and well 
tolerated in men with mild to moderate erectile dysfunction of no clinically identifiable 
organic cause (Eardley, 2001).  
With the presence of PDE5 in choroidal and retinal vessels sildenafil citrate increase 
choroidal blood flow and cause vasodilation of the retinal vasculature. The most common 
symptoms are a blue tinge to vision and an increased sensitivity to light (Kerr and Danesh-
Meyer, 2009). Adverse effects include headache, visual and retinal disturbances, dizziness 
and pupil-sparing third nerve palsy (Monastero et al., 2001). There have been reports of 
non-arteritic anterior ischaemic optic neuropathy and serous macular detachment in users of 
PDE5 inhibitors; although a causal relationship has not been conclusively shown. Despite 
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the role of cGMP in the production and drainage of aqueous humor these medications do 
not appear to alter intraocular pressure and are safe in patients with glaucoma. All PDE5 
inhibitors weakly inhibit PDE6 located in rod and cone photoreceptors resulting in mild and 
transient visual symptoms that correlate with plasma concentrations. Psychophysical tests 
reveal no effect on visual acuity, visual fields or contrast sensitivity; however, some studies 
show a mild and reversible impairment of blue-green colour discrimination. PDE5 inhibitors 
transiently alter retinal function on electroretinogram testing but do not appear to be 
retinotoxic. Despite the role of cyclic nucleotides in tear production there is no detrimental 
effect on tear film quality. Based on the available evidence PDE5 inhibitors have a good 
ocular safety profile (Kerr and Danesh-Meyer, 2009). 
It has been reported that sildenafil citrate significantly improves nocturnal penile erections 
in sildenafil non-responding patients with psychogenic erectile dysfunction (Abdel-Naser et 
al., 2004). Several pharmacological and physiological properties of sildenafil have been 
described (Cheitlin et al., 1999; Aviv et al., 2004; Galie et al., 2005; Hoeper et al., 2006)  
In Nigeria, most individuals often use sildenafil citrate indiscriminately for sexual arousal. 
There is a growing apprehension that it could be harmful or injurious to the body. Though 
sildenafil is currently being used to treat erectile dysfunction in patients with multiple 
sclerosis, Parkinson disease, multisystem atrophy, and spinal cord injury by improving their 
neurologically related erectile dysfunction, conversely, it has been implicated in a number of 
neurological problems, such as intracerebral hemorrhage, migraine, seizure, transient global 
amnesia, nonarteritic anterior ischemic optic neuropathy, macular degeneration, branch 
retinal artery occlusion, and ocular muscle palsies. Thus, preclinical and very limited clinical 
data suggest that sildenafil may have therapeutic potential in selected neurological 
disorders. However, numerous reports are available regarding neurological adverse events 
ascribed to the drug. Although sildenafil shows some promise as a therapeutic agent in 
selected neurological disorders, well-designed clinical trials are needed before the agent can 
be recommended for use in any neurological disorder (Farooq et al., 2008). 
The liver is the largest glandular organ of the body, weighing between 1.4-1.6kg. It lies 
below the diaphragm in the thoracic region of the abdomen. It plays a major role in 
metabolism and has a number of functions in the body, including glycogen storage, plasma 
protein synthesis, production of bile; an alkaline compound which aids in digestion, and 
detoxification of most substances (Gartner and Hiatt, 2000).  
The Kidney is a paired organ located in the posterior abdominal wall, whose functions 
include the removal of waste products from the blood and regulation of the amount of fluid 
and electrolytes balance in the body. As in humans, the majority of drugs administered are 
eliminated by a combination of hepatic metabolism and renal excretion (Katzung 1998). The 
kidney also plays a major role in drug metabolism, but its major importance to drugs is still 
its excretory functions.  
Since the liver and kidneys are involved in the performance of these varied functions they 
may be susceptible to injury particularly in situation of toxicity. This work is carried out to 
investigate the histological effects of Sildenafil citrate on the liver and kidneys of adult 
Wistar rat. Though there are little or no literature report of toxicity of this drug on these two 
organs, but because they are vital organs in the body it is worthwhile to study its effects on 
them. Though Daghfous et al., in 2005 reported that sildenafil-induced liver disease.  
This study will further corroborate or disprove the toxic effects of Sildenafil citrate in organs 
other than sex organs, with a view to advising the consumers on the inherent dangers of 
excessive consumption of the aphrodisiac. 
www.intechopen.com
The Effects of Sildenafil Citrate on the Liver  
and Kidneys of Adult Wistar Rats (Rattus norvegicus) – A Histological Study 
 
119 
2. Materials and methods 
Twenty-four (24) adult Wistar rats of both sexes, weighing between 220.5g and 233.8g, with 
an average weight of 222.3g were randomly assigned into three treatment (n=18) and 
control (n=6) groups. The rats were obtained and maintained in the Animal holdings of the 
Department of Anatomy, School of Basic Medical Sciences, University of Benin, Benin city, 
Nigeria. They were fed with growers’ mash obtained from Edo feed and flour mill limited, 
Ewu, Edo State and given water and feed ad libitum. The rats were acclimatized for 4 weeks 
before the experiment started.  
2.1 Sildenafil citrate administration  
The rats in the treatment groups (A, B, & C) received respectively, 0.25mg/kg, 0.70mg/kg 
and 1.43mg/kg body weight of Sildenafil citrate base dissolved in distilled water daily for 6 
weeks, through orogastric feeding tube, while that of the control group D, received equal 
volume of distilled water daily during the period of the experiment. The rats were sacrificed 
by cervical dislocation on day forty-three of the experiment. The liver and kidneys of the 
animals in each group were dissected out and quickly fixed in 10% formal saline for general 
histological studies.  
2.2 Histological study 
The liver and Kidney tissues were dehydrated in an ascending grade of alcohol (ethanol), 
cleared in xylene and embedded in paraffin wax. Serial sections of 7 microns thick were 
obtained using a rotatory microtome. The deparaffinised sections were stained routinely 
with hematoxylin and eosin reagent. Photomicrographs of the specimens were obtained 
using digital research photographic microscope in the University of Benin research 
laboratory.  
2.3 Liver enzyme assay and other metabolic panel  
Blood samples were collected from all the rats within different treatment groups through 
the orbital venous plexuses on the last day of the experiment under chloroform anaesthesia. 
Blood serum was separated by centrifugation at 3000 rpm for 15 min. Serum was analysed 
colorimetrically for total protein, albumin, transaminases (aspartate aminotransferase (AST) 
and alanine aminotransferase (ALT). Blood samples were also collected and analyzed for 
blood urea nitrogen (BUN) and serum creatinine (Scr) by using the commercial kits 
(McClatchey, 1994)  
2.4 Approval 
This study was given consent and approval for the methodology and other ethical issues 
concerning the work by the University of Benin Research Ethics Ccommittee.  
2.5 Statistical analysis 
The results were expressed as mean ±SD. Data obtained from liver function test, blood urea 
nitrogen (BUN) and serum creatinine (Scr) were subjected to statistical analysis using one 
way analysis of variance (ANOVA) then followed with post hoc test (Least Square 
Deviation), P value of less than 0.05 was considered significant.  
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3. Results 
3.1 Liver tissue 
The control sections of the liver showed normal histological features with the hepatic 
lobules showing irregular hexagonal boundary defined by portal tract and sparse 
collagenous tissues. The hepatic portal veins, bile ductules and hepatic artery within the 
portal tract were all visible (Figure 1).  
The treatment sections of the liver showed some histological changes that were at variance 
with those obtained in the control. There were evidence of dilatations of the central veins, 
which contained lysed red blood cells and cyto-architectural distortions of the hepatocytes and 
centrilobular haemorrhagic necrosis. There were atrophic and degenerative changes with the 
group that received 1.43mg/kg body weight of Sildenafil citrate more (Figure 2, 3 & 4).  
 
 
Fig. 1. Control section of the liver. Group ‘D’ (Mag. X400)  
 
 
Fig. 2. Photomicrograph of the liver showing in the treatment groups ‘A’ that received 
0.25mg/kg body weight of Sildenafil citrate. It shows portal tract and sparse collagenous 
tissues. The liver sinusoid and central veins were visible (Mag. x400) 
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Fig. 3. Photomicrograph of the liver showing in the treatment groups ‘B’ that received 
0.70mg/kg body weight of Sildenafil citrate. There were atrophic and degenerative changes 
around the hepatocytes and central vein, which was dilated and contained lysed red blood 
cell (Mag. X400). 
 
 
Fig. 4. Photomicrograph of the liver showing in the treatment groups ‘C’ that received 
1.43mg/kg body weight of Sildenafil citrate. There were marked atrophic and degenerative 
changes around the hepatocytes and lysed red blood cell containing dilated central vein 
(Mag. X400). 
3.2 Kidney tissue 
The control sections of the kidneys showed normal histological features. The section indicated 
a detailed cortical parenchyma and the renal corpuscles appeared as dense rounded structures 
with the glomerulus surrounded by a narrow Bowman’s spaces (Figure 5)  
The kidneys of the animals in group ‘A’ treated with 0.25mg/kg of Sildenafil citrate 
revealed some level of cyto-architectural distortion of the cortical structures as compared to 
the control (Figure 6)  
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Fig. 5. Control section of the Kidney. Group ‘D’ (Mag. X400) 
 
 
 
 
Fig. 6. Photomicrograph of the Kidney showing in the treatment groups ‘A’ that received 
0.25mg/kg body weight of Sildenafil citrate showing some level of cyto-architectural 
distortion of the cortical structures (Mag. X400) 
The kidney sections of animals in group ‘B’ treated with 0.70mg/kg of Sildenafil citrate 
revealed mild to moderate distortion of cyto-architecture of the renal cortical structures with 
mild degenerative and atrophic changes. The kidney sections of animals in group ‘C’ treated 
with 1.43mg/kg of Sildenafil citrate revealed marked distortion of cyto-architecture of the 
renal cortical structures, and degenerative and atrophic changes. There were vacuolations 
appearing in the stroma and loss of renal corpuscles which were less identified and the 
Bowman’s spaces were sparsely distributed as compared to the control group ‘D’ (Figure 7) 
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Fig. 7. Photomicrograph of the Kidney showing in the treatment groups ‘B’ that received 
0.70mg/kg body weight of Sildenafil citrate mild to moderate distortion of cyto-architecture 
of the renal cortical structures with mild degenerative and atrophic changes (Mag. X400) 
 
 
Fig. 8. Photomicrograph of the Kidney showing in the treatment groups ‘B’ that received 
1.43mg/kg body weight of Sildenafil citrate marked distortion of cyto-architecture of the 
renal cortical structures, and degenerative and atrophic changes. There were vacuolations 
appearing in the stroma and loss of renal corpuscles which were less identified and the 
Bowman’s spaces were sparsely distributed.  
Table 1 below shows the mean and standard deviation of each group for the different 
components. The table revealed that experimental group C (Exp. C) has the highest mean 
for components: Total Protein, Albumin, ALT and AST. The Control group had the least 
mean for all the components. 
Table 2 shows the analysis of variance for the four groups for the five components. The 
results revealed that the difference between the means of the four groups for each 
component is significant (P <0.0001). 
The result of this experiment revealed that Sildenafil citrate consumption caused significant 
(P<0.05) increase in functional nephrotoxicity indicators such as BUN and Serum creatinin 
in Sildenafil citrate-treated rats compared with control (Table 3).  
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 Group  N  Mean  Std. Deviation  Std. Error  
Protein (g/dl) Control  
Exp. A 
Exp. B 
Exp. C 
 
6 
6 
6 
6 
4.46 
5.73 
6.69 
7.73 
0.59 
0.21 
0.37 
0.42 
 
0.19 
0.04 
0.10 
0.12 
 Total  24 6.68 0.98 0.22 
Albumin (g/dl)  Control  
Exp. A 
Exp. B 
Exp. C 
 
6 
6 
6 
6 
2.83 
3.45 
4.31 
5.23 
0.38 
0.26 
0.29 
0.34 
 
0.16 
0.07 
0.09 
0.13 
 Total  24 3.66 0.69 0.17 
ALT (μmol/l) Control  
Exp. A 
Exp. B 
Exp. C 
 
6 
6 
6 
6 
32.42 
73.84 
108.66 
112.73 
0.51 
11.63 
27.03 
29.42 
 
0.26 
4.34 
8.60 
9.71 
 Total  24 78.34 35.20 7.84 
AST (μmol/l)  Control  
Exp. A 
Exp. B 
Exp. C 
 
6 
6 
6 
6 
13.60 
58.70 
79.82 
88.57 
0.61 
8.84 
29.37 
32.62 
 
0.28 
3.16 
9.90 
11.72 
 Total  24 53.16 35.45 6.84 
Table 1. Descriptive statistics, protein and some liver enzymes assay of groups. 
 
 Source of Variation  
 
Sum of Squares  df Mean Square  F  Sig.  
Protein  
 
Between Groups 
Within groups 
Total  
17.612  
1.978 
18.282 
3 
21
24
8.560 
0.096  
91.528  .000  
Albumin  
 
Between Groups 
Within groups 
Total  
7.749  
1.881 
8.976 
3 
21
24
3.471 
0.083  
60.21  .000  
ALT  
 
Between Groups 
Within groups 
Total  
  
19421.463  
5627.238  
25570.766  
 
3 
21
24
9823.571  
302.135  
 
31.791  .000  
AST  
 
Between Groups 
Within groups 
Total  
13873.376  
5724.897  
18.898 
3 
21
24
6936.688  
301.310  
 
23.022  .000  
P <0.0001 
Table 2. Analysis of Variance (ANOVA) of the Four Groups 
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 BUN (mg/dl) Scr (mg/dl) 
Control 14.38±2.5  0.47±0.21  
Experimental group A (0.25mg/kg) 28.7±4.63  2.3±0.23  
Experimental group B (0.70mg/kg) 55±0.72  3.2±0.99  
Experimental group C (1.43mg/kg) 69±0.33  3.8±2.62  
Table 3. Effects of Sildenafil citrate consumption on BUN and Scr concentration  
4. Discussion 
The results of the histological studies revealed that with increasing dose of Sildenafil citrate 
consumption, there were varying degrees of dilatations of the central vein of the liver which 
contained lysed red blood cells in the treatment group compared to the control sections of 
the liver, and as well as varying degree of cyto-architectural distortion and reduction in the 
number of renal corpuscle in the kidneys of the treated groups compared to the control 
sections of the kidneys. This suggests that the distortion of the cyto-architecture of the liver 
could be associated with functional changes that may be detrimental to the health of the 
rats. The proliferating cells of the liver, which produce red and white blood cells, are 
normally found between the hepatic cells and the walls of the vessels (Singh, 1997). 
As a result of the distortion and dilatation of the hepatocytes and their central vein, the 
haematopoietic function of the liver may have been highly affected as a result of probable 
toxic effect of Sildenafil citrate. This was further buttressed by the increase in the liver 
enzymes obtained in the test group. In addition, total protein and albumin increased in this 
study the increase in total protein may be due to the fact that Sildenafil citrate was given for 
a short period of time. The resultant effect is acute toxicity leading to enhanced hepato-
cellullar activity and increase in globulin and albumin components of the protein .However, 
with prolonged usage, hepatic necrosis is likely to occur with a resultant low albumin levels.  
There were several diffuse degeneration and necrosis of the tubular epithelial cells in the 
kidneys of the treated animals. The degenerative and atrophic changes where observed more 
in the kidneys of rats that received the highest dose (1.43mg/kg) of Sildenafil citrate.  
It may be inferred from the present results that higher doses of Sildenafil citrate 
consumption may have resulted in degenerative and atrophic changes observed in the renal 
corpuscle. The possible deduction from these results is that secondary metabolites, which 
are largely responsible for therapeutic or pharmacological activities of medicinal plants 
(Perry, 1980), may also account for their toxicity when the dosage is abused.  
Pathological or accidental cell death is regarded as necrotic and could result from extrinsic 
insults to the cell as osmotic thermal, toxic and traumatic effect (Farber et al, 1981). 
Physiological cell death is regarded as apoptotic and organized programmed cell death 
(PCD) that is mediated by active and intrinsic mechanisms. The process of cellular necrosis 
involves disruption of membranes, as well as structural and functional integrity. Cellular 
necrosis is not induced by stimuli intrinsic to the cells as in programmed cell death (PCD), 
but by an abrupt environmental perturbation and departure from the normal physiological 
conditions (Farber et al, 1981).  
Cellular degeneration has been reported to result in cell death, which is of two types, namely 
apoptotic and necrotic cell death. These two types differ morphologically and biochemically 
(Wyllie, 1980). Pathological or accidental cell death is regarded as necrotic and could result 
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from extrinsic insults to the cell such as osmotic, thermal, toxic and traumatic effects (Wyllie, 
1980). Cell death in response to toxins occurs as a controlled event involving a genetic 
programme in which caspase enzymes are activated (Waters et al., 1994).  
As the hepatocytes swell as seen in this study the activities of cellular transporters are 
approximately modified by up or down regulations as earlier reported in the case of 
hyponatraemia or hypernatraemia (Johnson, 1995). Ischaemic or pharmacologic disruption 
of cellular transporters can cause swelling of parenchyma of the liver cells. Sildenafil citrate 
may have acted as toxins to the hepatocytes, thereby affecting their cellular integrity and 
causing defect in membrane permeability and cell volume homeostasis.  
The actual mechanism by which Sildenafil citrate induced cellular degeneration observed in 
this experiment needs further investigation. The necrosis observed is probably due to the high 
concentration of Sildenafil citrate on the liver and kidney; this obviously will affect the normal 
detoxification, excretory processes and other functions of the liver and kidneys respectively.  
The limitation of this study was the duration of study (acute) as opposed to chronic which 
could have yielded more light on the pathology.  
5. Conclusion 
The results obtained in this study following the administration of 0.25mg/kg, 0.70mg/kg 
and 1.43mg/kg per day of Sildenafil to adult Wistar rats affected the histology of the liver 
and kidneys. These results suggest that the functions of the liver and kidney may have been 
adversely affected. It is recommended that caution should therefore be advocated in the 
intake of this product and further studies be carried out to examine these findings. 
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